Literature for SNJ-1945 (C02.001, C02.002 inhibitor)

(Topics flags: S Structure, P Specificity, I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2014
1. Nakajima,T., Shearer,T.R. and Azuma,M.
   Loss of calpastatin leads to activation of calpain in human lens epithelial cells
   Invest Ophthalmol Vis Sci55, 5278-5283. PubMed  Europe PubMed DOI  I
2011
2. Liu,M.C., Kobeissy,F., Zheng,W., Zhang,Z., Hayes,R.L. and Wang,K.K.
   Dual vulnerability of tau to calpains and caspase-3 proteolysis under neurotoxic and neurodegenerative conditions
   ASN Neuro3, e00051-e00051. PubMed  Europe PubMed DOI  P  I
2008
3. Azuma,M. and Shearer,T.R.
   The role of calcium-activated protease calpain in experimental retinal pathology
   Surv Ophthalmol53, 150-163. PubMed  Europe PubMed DOI  I
4. Koumura,A., Nonaka,Y., Hyakkoku,K., Oka,T., Shimazawa,M., Hozumi,I., Inuzuka,T. and Hara,H.
   A novel calpain inhibitor, ((1S)-1((((1S)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl )-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester, protects neuronal cells from cerebral ischemia-induced damage in mice
   Neuroscience157, 309-318. PubMed  Europe PubMed DOI  I
2006
5. [YEAR:20-6-2006]Cuerrier,D., Moldoveanu,T., Inoue,J., Davies,P.L. and Campbell,R.L.
   Calpain inhibition by alpha-ketoamide and cyclic hemiacetal inhibitors revealed by X-ray crystallography
   Biochemistry45, 7446-7452. PubMed  Europe PubMed DOI  S  I
6. Shirasaki,Y., Yamaguchi,M. and Miyashita,H.
   Retinal penetration of calpain inhibitors in rats after oral administration
   J Ocul Pharmacol Ther22, 417-424. PubMed  Europe PubMed DOI  I
2005
7. [YEAR:24-5-2005]Shirasaki,Y., Miyashita,H., Yamaguchi,M., Inoue,J. and Nakamura,M.
   Exploration of orally available calpain inhibitors: peptidyl alpha-ketoamides containing an amphiphile at P3 site
   Bioorg Med Chem13, 4473-4484. PubMed  Europe PubMed DOI  I